A

Amgen

Makes biotech medicines for serious illnesses

Director, AI and Machine Learning

AI ResearchPosted on Nov 11
Full-time

About the Job

Requirements

  • A doctorate degree and 4 years of relevant overall experience in computational biology, bioinformatics, quantitative science, data science, machine learning, or a related field; or a master's degree and 8 years of relevant overall experience in those fields; or a bachelor's degree and 10 years of relevant overall experience in those fields.
  • At least 4 years of experience directly managing people and/or leading teams, projects, or programs, or directing resource allocation; this experience may be concurrent with the required technical experience.

Responsibilities

  • Define and execute the group's AI and machine learning strategy across therapeutic areas, prioritizing reusable capabilities for clinical development questions and regulatory evidence needs, and translate scientific priorities into a coordinated roadmap for methods, platforms, and analytical products.
  • Partner with therapeutic area computational biology leaders and program-facing scientists to integrate shared capabilities into development workflows, balancing innovation, delivery, adoption, resource needs, and operating costs.
  • Influence Precision Medicine AI and machine learning strategy.
  • Lead the architecture and evolution of the group's analytics stack, spanning data preparation and integration, computational workflows, model development, evaluation, deployment, and scientific interpretation in clinical development settings.
  • Partner with enterprise technology, data engineering, security, and infrastructure teams to deliver scalable AWS-based computing and AI capabilities aligned with enterprise architecture and governance.
  • Establish reusable software, workflows, and standards for reproducibility, version control, testing, documentation, data lineage, and ongoing platform and model operations.
  • Lead the development and application of statistical, machine learning, deep learning, and other AI methods to integrate multi-omics, imaging, biomarker, and clinical data from human studies.
  • Develop reusable approaches for patient stratification, response prediction, pharmacodynamic analysis, and mechanism-of-action studies, linking biomarker and imaging findings to clinical endpoints, efficacy, and safety.
  • Direct cross-study and cross-asset analyses that support translation and reverse translation, using biological hypotheses to inform clinical biomarker strategies and clinical observations to generate mechanistic hypotheses for experimental testing and future studies.
  • Anchor analytical strategies in clinical trial design, endpoints, patient populations, assay limitations, confounding, missing data, and uncertainty.
  • Apply validation appropriate to the scientific question, clinical decision, and intended evidentiary use.
  • Identify and prioritize evidence gaps across clinical programs and therapeutic areas, and determine where additional human datasets could strengthen biomarker interpretation, predictive models, and clinical or regulatory evidence generation.
  • Lead scientific and analytical evaluation of external human datasets, recommending which to acquire, license, and internalize based on relevance to priority questions, population and outcome coverage, data quality, reuse potential, permitted uses, and integration requirements.
  • Lead agentification of existing analytical workflows, redesigning repeatable steps with AI assistants and coordinated agents to increase operational productivity and reduce routine manual quality-control effort.
  • Automate routine validation, consistency checks, and quality-control triage, directing exceptions and scientific interpretation to appropriate experts with traceable review decisions.
  • Guide the use of Codex and other enterprise-approved AI tools to develop and orchestrate agent-enabled workflows connecting scientific data, analytical tools, models, and expert review.
  • Establish evaluation and monitoring approaches for scientific accuracy, reliability, reproducibility, appropriate tool use, and human oversight.
  • Embed data privacy, access controls, provenance, model documentation, and fit-for-purpose quality practices into shared capabilities used with sensitive human data and clinical analytical workflows.
  • Partner with biostatistics, clinical development, precision medicine, regulatory, safety, medical, and quality colleagues to align analysis plans with clinical and regulatory evidence needs and document assumptions, limitations, and interpretation.
  • Enable traceable, scientifically reviewed analyses for clinical development decisions, regulatory submissions and health authority questions, publications, and medical and scientific communications, with evidence standards appropriate to each intended use.
  • Manage, coach, and develop a scientific and technical team; set clear priorities and performance expectations; and build an inclusive culture of scientific rigor, collaboration, and accountability.
  • Strengthen AI fluency across computational biologists, bioinformaticians, statisticians, mathematicians, data scientists, machine learning scientists, and engineers through practical demonstrations, training, and collaboration.
  • Lead adoption of new tools and working practices, and track improvements in analytical turnaround time, manual quality-control effort, reuse, adoption, scientific quality, and decision value.
  • Communicate strategy, results, investment needs, and trade-offs clearly to scientific, technical, and executive audiences.

Desired Qualifications

  • Demonstrated AI and machine learning experience, including development, evaluation, and delivery of computational methods or capabilities that address substantive scientific problems.
  • Recognized scientific eminence in AI and machine learning, computational biology, or translational science, demonstrated by a sustained record of influential peer-reviewed publications and contributions that advance methods or scientific practice.
  • Experience analyzing or integrating complex human multimodal data, including multi-omics, imaging, clinical biomarkers, or clinical outcomes, with an understanding of the challenges of high-dimensional biomedical data.
  • Experience delivering translational analytics in clinical drug development, with an understanding of clinical trial design, endpoints, biomarker analysis plans, and the documentation and review needed for regulatory evidence generation.
  • Practical familiarity with Codex, AI-assisted development, and the development and orchestration of AI agents; familiarity with enterprise generative and agentic AI solutions and their integration into scientific workflows.
  • Familiarity with AWS infrastructure, cloud-based analytical environments, and the requirements for scalable scientific computing and AI and machine learning delivery.
  • Ability to lead across functions, influence stakeholders, manage competing priorities, and communicate complex scientific and technical concepts clearly.
  • At least 15 years of relevant overall experience in computational biology, bioinformatics, quantitative science, data science, machine learning, or related fields.
  • A PhD in a relevant computational, quantitative, engineering, or biomedical discipline.
  • Demonstrated success taking scientific AI and machine learning capabilities from research or prototype into routine organizational use.
  • Experience developing reusable methods for multimodal integration, predictive modeling, or cross-study learning across more than one therapeutic area.
  • Experience with modern software engineering, MLOps, model evaluation, and the operation of enterprise AI systems.
  • Experience leading organizational change and helping multidisciplinary teams adopt new analytical technologies and working practices.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs